Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.
about
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune ResponseImmune Cells and Inflammation in Diabetic NephropathyTargeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor ImmunityLoss of B Cells in Patients with Heterozygous Mutations in IKAROS.Rabex-5 is a lenalidomide target molecule that negatively regulates TLR-induced type 1 IFN productionOrigin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.Role of Ets Proteins in Development, Differentiation, and Function of T-Cell Subsets.IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide-dexamethasone therapy in multiple myeloma.Fine-Tuning of CD8(+) T Cell Mitochondrial Metabolism by the Respiratory Chain Repressor MCJ Dictates Protection to Influenza VirusIL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.Mechanisms regulating T-cell infiltration and activity in solid tumors.Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients
P2860
Q26744527-A608F86E-64EB-4580-8E6D-17C12362480AQ26772998-8F3673A9-0769-4EDE-9476-6BD0D4523CFEQ26782201-0F1F954A-943A-4FD9-A912-7C33CB28F60FQ30356529-FFDA0522-8398-43ED-82D1-0E683B740903Q37281544-356DDA99-05A9-4580-BE24-FDED6B0E7A1AQ38413010-91E969FE-8FC5-4676-AE3E-2D62134C741EQ38572497-8CF9C693-C2FE-4604-A4B2-63844FE5A5EFQ39040840-E79A451F-B974-4738-9009-CCA2C54DDCAEQ40656271-2D46C1A1-5332-42EA-846C-DBA1BB88770AQ46768284-7EF45FDD-E5D4-44B8-9CF4-1CF06E38CE9CQ49960388-F3828858-31E5-4D74-86B9-4C9B0E31C1B6Q50089395-C8ACAE03-1F78-43C4-A211-0F6D75AAEFDBQ58552961-59C3816D-0C08-4AEC-9B34-69D6F2866D8A
P2860
Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Ikaros imposes a barrier to CD ...... ing autocrine IL-2 production.
@en
Ikaros imposes a barrier to CD ...... ing autocrine IL-2 production.
@nl
type
label
Ikaros imposes a barrier to CD ...... ing autocrine IL-2 production.
@en
Ikaros imposes a barrier to CD ...... ing autocrine IL-2 production.
@nl
prefLabel
Ikaros imposes a barrier to CD ...... ing autocrine IL-2 production.
@en
Ikaros imposes a barrier to CD ...... ing autocrine IL-2 production.
@nl
P2093
P2860
P356
P1476
Ikaros imposes a barrier to CD ...... ing autocrine IL-2 production.
@en
P2093
Andrew D Wells
Fuqin Zhang
Gerald B Wertheim
Rajan M Thomas
Shaun O'Brien
P2860
P304
P356
10.4049/JIMMUNOL.1301992
P407
P577
2014-04-28T00:00:00Z